Portal de Periódicos da CAPES

Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City

2022; SAGE Publishing; Volume: 9; Linguagem: Inglês

10.1177/20499361211069264

2049-937X

Rosa María Wong‐Chew, Edwin Xchel Rodríguez Cabrera, Carlos Alberto Rodríguez Valdez, Julieta Lomelín‐Gascón, Linda Morales‐Juárez, Mariana Lizbeth Rodríguez de la Cerda, Antonio Rafael Villa-Romero, Stephanie Arce Fernández, Mariana Serratos Fernández, Héctor Herrera Bello, Lidia Moreno Castañeda, Mónica Avendaño, Jesús Abraham Hernández-Cruz, Nelson Álvarez Martínez, Liza Fernanda Contreras, Luis Rafael González de la Cerda, Arturo Juárez Flores, Luis Alberto Martínez‐Juárez, Diego-Abelardo Álvarez-Hernández, Héctor Gallardo‐Rincón, Germán Fajardo-Dolci, Roberto Tapia‐Conyer, Rafael Ricardo Valdez‐Vázquez,

Intensive Care Unit Cognitive Disorders

Several reports have emerged describing the long-term consequences of COVID-19 and its effects on multiple systems. As further research is needed, we conducted a longitudinal observational study to report the prevalence and associated risk factors of the long-term health consequences of COVID-19 by symptom clusters in patients discharged from the Temporary COVID-19 Hospital (TCH) in Mexico City. Self-reported clinical symptom data were collected via telephone calls over 90 days post-discharge. Among 4670 patients, we identified 45 symptoms across eight symptom clusters (neurological; mood disorders; systemic; respiratory; musculoskeletal; ear, nose, and throat; dermatological; and gastrointestinal). We observed that the neurological, dermatological, and mood disorder symptom clusters persisted in >30% of patients at 90 days post-discharge. Although most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased (p < 0.00001). Women were more prone than men to develop long-term symptoms, and invasive mechanical ventilation also increased the frequency of symptoms at 30 days post-discharge. Overall, we observed that symptoms often persisted regardless of disease severity. We hope these findings will help promote public health strategies that ensure equity in the access to solutions focused on the long-term consequences of COVID-19.